End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
72.66 CNY | -0.16% | +11.27% | -24.94% |
Apr. 25 | Micro-Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | Tranche Update on Micro-Tech Co.,Ltd's Equity Buyback Plan announced on February 5, 2024. | CI |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.94% | 1.89B | C | ||
-3.72% | 186B | C+ | ||
-2.60% | 107B | C | ||
-3.79% | 67.44B | A | ||
+2.66% | 50.03B | B- | ||
+16.39% | 47.81B | B- | ||
+4.79% | 41.03B | B+ | ||
+1.38% | 26.85B | B | ||
+1.52% | 25.82B | A- | ||
-1.17% | 25.01B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 688029 Stock
- Ratings Micro-Tech (Nanjing) Co.,Ltd